Wieacker-Wolff syndrome with hyperinsulinemic hypoglycemia successfully treated using diazoxide: A case report.

Satoko Kobayashi, Ayami Sato, Yumiko Chiba, Natsuho Adachi, Yu Kakimoto, Hisato Suzuki, Mamiko Yamada, Kenjiro Kosaki, Hiroyuki Tanaka
Author Information
  1. Satoko Kobayashi: Department of Pediatrics, The University of Tokyo, Tokyo, Japan.
  2. Ayami Sato: Department of Pediatrics, The University of Tokyo, Tokyo, Japan.
  3. Yumiko Chiba: Department of Pediatrics, The University of Tokyo, Tokyo, Japan.
  4. Natsuho Adachi: Department of Pediatrics, The University of Tokyo, Tokyo, Japan.
  5. Yu Kakimoto: Department of Pediatrics, The University of Tokyo, Tokyo, Japan.
  6. Hisato Suzuki: Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan.
  7. Mamiko Yamada: Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan.
  8. Kenjiro Kosaki: Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan.
  9. Hiroyuki Tanaka: Department of Pediatrics, The University of Tokyo, Tokyo, Japan.

Abstract

Wieacker-Wolff syndrome (WRWF) is an X-linked genetic disorder characterized by neuromusculoskeletal abnormalities caused by loss-of-function variants of the gene. Here, we report the case of a male infant with WRWF manifesting as multiple joint contractures and congenital anomalies at birth. He underwent gastrostomy to treat the gastroesophageal reflux disease, which caused mixed apnea and transient bradycardia. The patient subsequently developed hyperinsulinemic hypoglycemia (HH) and was diagnosed with dumping syndrome. Although he underwent multiple treatments, including alpha-glucosidase inhibitors (α-GI) administration, he continued to exhibit HH with seizures and loss of consciousness. Whole-exome sequencing revealed a novel missense variant of [NM_018684.4: c.557T>G, p.(Met186Arg)] at Xq11.2 in both the patient and his mother. Based on these results and clinical symptoms, the patient was diagnosed with WRWF. Although WRWF is not considered a major cause of HH, we regarded it as a related complication based on previous reports. Diazoxide treatment was initiated, and the hypoglycemic attacks resolved almost entirely without any notable side effects after 18 mo. To the best of our knowledge, this is the first report of WRWF-associated HH treated with low-dose diazoxide and α-GI. Therefore, diazoxide is recommended for the treatment of WRWF-associated HH.

Keywords

References

  1. J Pediatr Endocrinol Metab. 2018 Dec 19;31(12):1325-1333 [PMID: 30447143]
  2. Brain Dev. 2018 Oct;40(9):760-767 [PMID: 29803542]
  3. J Endocr Soc. 2019 Jun 05;3(7):1357-1360 [PMID: 31286099]
  4. Clin Genet. 2023 Feb;103(2):167-178 [PMID: 36250278]
  5. Clin Pediatr Endocrinol. 2018;27(3):131-143 [PMID: 30083030]
  6. Cell Death Dis. 2023 Jul 5;14(7):399 [PMID: 37407581]
  7. Genes (Basel). 2022 Aug 29;13(9): [PMID: 36140726]
  8. Am J Med Genet A. 2018 Jan;176(1):167-170 [PMID: 29150902]
  9. Hum Mutat. 2019 Dec;40(12):2270-2285 [PMID: 31206972]
  10. J Clin Endocrinol Metab. 2020 Dec 1;105(12): [PMID: 32810255]
  11. Am J Hum Genet. 2013 May 2;92(5):681-95 [PMID: 23623388]
  12. Front Neurol. 2021 Jul 12;12:704747 [PMID: 34322088]
  13. Am J Med Genet. 1985 Apr;20(4):597-606 [PMID: 4039531]
  14. Endocrinol Diabetes Metab Case Rep. 2024 Mar 01;2024(1): [PMID: 38432066]
  15. Genet Med. 2015 May;17(5):405-24 [PMID: 25741868]
  16. J Biol Chem. 2009 May 1;284(18):12246-57 [PMID: 19265200]
  17. Open Biol. 2017 Aug;7(8): [PMID: 28814648]
  18. Hum Mol Genet. 2015 Sep 1;24(17):4848-61 [PMID: 26056227]

Word Cloud

Created with Highcharts 10.0.0HHsyndromeWRWFreportpatienthyperinsulinemichypoglycemiadiazoxideWieacker-WolffcausedcasemultipleunderwentdiagnosedAlthoughalpha-glucosidaseinhibitorsα-GItreatmentWRWF-associatedtreatedX-linkedgeneticdisordercharacterizedneuromusculoskeletalabnormalitiesloss-of-functionvariantsgenemaleinfantmanifestingjointcontracturescongenitalanomaliesbirthgastrostomytreatgastroesophagealrefluxdiseasemixedapneatransientbradycardiasubsequentlydevelopeddumpingtreatmentsincludingadministrationcontinuedexhibitseizureslossconsciousnessWhole-exomesequencingrevealednovelmissensevariant[NM_0186844:c557T>GpMet186Arg]Xq112motherBasedresultsclinicalsymptomsconsideredmajorcauseregardedrelatedcomplicationbasedpreviousreportsDiazoxideinitiatedhypoglycemicattacksresolvedalmostentirelywithoutnotablesideeffects18mobestknowledgefirstlow-doseThereforerecommendedsuccessfullyusingdiazoxide:Wieacker–WolffZC4H2

Similar Articles

Cited By